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RESEARCH ARTICLE Open Access
Peroperative epicardial ultrasonography of
distal coronary artery bypass graft
anastomoses using a stabilizing device. A
feasibility study
Jan Jesper Andreasen1,2* , Dorte Nøhr1, Alex Skovsbo Jørgensen3 and Poul Erik Haahr1
Abstract
Background: Widespread use of intraoperative epicardial ultrasonography (ECUS) for quality assessment of coronary
artery bypass graft anastomoses during coronary artery bypass grafting (CABG) has not occurred - presumably due to
technological and practical challenges including the need to maintain stable and optimal acoustic contact between
the ultrasound probe and the target without the risk of distorting the anastomosis. We investigated the feasibility of
using a stabilizing device during ultrasound imaging of distal coronary bypass graft anastomoses in patients
undergoing on-pump CABG. Imaging was performed in both the longitudinal and transverse planes.
Methods: Single-centre, observational prospective feasibility study among 51 patients undergoing elective, isolated
on-pump CABG. Ultrasonography of peripheral coronary bypass anastomoses was performed using a stabilizing device
upon which the ultrasound transducer was connected. Transit-time flow measurement (TTFM) was also performed.
Descriptive statistical tests were used.
Results: Longitudinal and transverse images from the heel, middle and toe were obtained from 134 of 155 coronary
anastomoses (86.5%). After the learning curve (15 patients), all six projections were obtained from 100 of 108
anastomoses scanned (93%). Failure to obtain images were typical due to a sequential curved graft with anastomoses
that could not be contained in the straight cavity of the stabilizing device, echo artefacts from a Titanium clip located
in the roof of the anastomoses, and challenges in interpreting the images during the learning curve. No complications
were associated with the ECUS procedure. The combined ECUS and TTFM resulted in immediate revision of five
peripheral anastomoses.
Conclusions: Peroperative use of a stabilizing device during ultrasonography of coronary artery bypass anastomoses in
on-pump surgery facilitates imaging and provides surgeons with non-deformed longitudinal and transverse images of
all parts of the anastomoses in all coronary territories. Peroperative ECUS in addition to flow measurements has the
potential to increase the likelihood of detecting technical errors in constructed anastomoses.
Trial registration: The study was registered on September 29, 2016, ClinicalTrials.gov ID: NCT02919124.
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Background
Intraoperative quality assessment of peripheral coronary
anastomoses during coronary artery bypass grafting
(CABG) offers surgeons the opportunity to detect tech-
nical failures mandating revision of the bypass graft before
chest closure. Several methods for quality assessment are
in use, including intraoperative selective coronary angiog-
raphy, transit-time flow measurement (TTFM), intraoper-
ative fluorescence imaging and high-frequency epicardial
ultrasonography (ECUS) [1–3].
High-frequency intraoperative ECUS has been used for
more than three decades [4], and this technique has
shown to be complementary to TTFM for improving the
diagnostic accuracy during graft assessment [5]. However,
widespread use of intraoperative ECUS for quality assess-
ment of coronary artery bypass graft anastomoses during
CAGB procedures has not been adopted, presumably due
to technological and practical challenges.
Among these challenges are maintaining stable and opti-
mal acoustic contact between the ultrasound probe and
examining the anastomosis without the risk of distorting it.
To overcome these challenges, we developed an ultrasound
transducer positioning device. This device can be used for
stabilizing the involved part of the myocardium on the con-
tracting/beating heart and for positioning of the ultrasound
transducer correctly for imaging of anastomoses in the
longitudinal and transverse planes without deforming the
anastomoses [6].
The primary objective of the present study was to in-
vestigate the ultrasound imaging procedure’s feasibility
in producing images of coronary artery bypass anasto-
moses in patients undergoing on-pump CABG both in
the longitudinal and transverse planes using a stabilizing
device. The secondary aims were to evaluate the safety
of the procedure and to register whether surgeons
revised any of the coronary anastomoses based on the
findings from ECUS and TTFM.
We hypothesized that use of the stabilizing device
would safely facilitate ECUS imaging of the heel, middle
and toe of at least 80% of all peripheral coronary bypass
anastomoses both in the longitudinal and transverse
planes during on-pump CABG.
Methods
Patients
This was a single-centre, observational prospective feasibil-
ity study among patients undergoing elective, isolated on-
pump CABG in the Department of Cardiothoracic Surgery,
Aalborg University Hospital, Denmark. Between 100 and
150 isolated, elective CABG procedures (approximately
20% off-pump) are performed each year. The study was ap-
proved by the Regional Ethical Committee (N-20160012),
the Danish Medicines Agency (ref. 2,016,020,479), and the
Danish Data Protection Agency (2008-58-0028). Written
informed consent was obtained from all participants. Trial
registration: ClinicalTrials.gov ID: NCT02919124; Regis-
tered September 29, 2016.)
Inclusion criteria were elective patients with an age ≥
18 years scheduled for on-pump CABG. Logistic euro-
SCORE II should be < 6, and surgery was to be per-
formed by a non-trainee surgeon in order to keep the
time for surgery including the cross-clamp and perfusion
time as low as possible during the study.
Exclusion criteria were conversion to or planned off-
pump surgery and urgent or emergent surgery. ECUS was
cancelled and the patient excluded from the study if the
surgeon decided to end the surgery as fast as possible due
to haemodynamic challenges or peroperative complications.
Other exclusion criteria were pregnant or lactating patients.
Clinical characteristics and preoperative laboratory data
were collected in all patients: age, gender, height and weight,
p-creatinine, estimated glomerular filtration rate, hyperten-
sion requiring medical treatment, diabetes, hypercholesterol-
emia requiring treatment, history of atrial fibrillation,
smoking status (active, stopped, or never smoked), left ven-
tricular ejection fraction, logistic euroSCORE II, number of
diseased (≤50% stenotic) coronary vessels (1–2 or 3 vessel
disease), > 50% left main stenosis, and preoperative anti-
thrombotic or anticoagulation medication within 5 days.
Fractional flow reserve measurement was performed if
there was a suspicion of a coronary artery stenosis being
non-significant. In general, patients continued ongoing
β-blocker and acetylsalicylic acid treatment until surgery,
but other antithrombotic drugs and orally anticoagulants
were discontinued before surgery.
Surgical procedure and postoperative medical treatment
Surgery was performed on-pump, and routine surgical,
anaesthetic and cardiopulmonary bypass procedures were
employed. All patients received perioperative prophylactic
anti-fibrinolytic treatment with 1.5 g tranexamic acid
(Stragen Nordic A/S) as an intravenous bolus followed by a
constant infusion of 200mg/h until 1.5 g. In all cases,
transoesophageal echocardiography was available. Cold
blood cardioplegia was administered in the aortic root
every 20min during aortic cross-clamping. Additional car-
dioplegia was infused directly into a free graft just after an
anastomosis was performed, keeping the flow approxi-
mately 60ml/min and the pressure below 100mmHg. The
graft compositions and types of conduits used were at the
discretion of the surgeon. In general, the left internal mam-
mary artery (LIMA) was anastomosed to the left anterior
descending artery (LAD) whenever this vessel was to be
grafted. LIMA and the right internal mammary artery
(RIMA) were harvested either skeletonised or non-
skeletonised and used as either in situ grafts or free grafts.
Both single and sequential grafts were used. Radial arteries
(RAs) were harvested using an open technique and in
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general used on the left-sided coronary arteries if the target
vessel was at least 70% stenotic. Saphenous vein grafts
(SVGs) were harvested using either an open or endoscopic
technique. Side branches from all conduits were closed
using titanium ligation clips (Symmetry Surgical,
Germany). All RAs and SVGs were gently flushed after
harvesting and kept at room temperature in a blood-based
solution containing saline, heparin (SAD, Amgros I/S,
Denmark) and papaverin (Aalborg University Hospital,
Denmark).
A decision to revise a peripheral anastomosis was based
on the combined findings from TTFM and ECUS and left
to the discretion of the surgeon, who also considered the
quality of the target vessel.
If an anastomosis was to be revised, the graft was
divided just proximal to the heel of the anastomosis. The
roof of the anastomosis was opened to inspect the inner
part of the anastomosis and search for a possible technical
error inside the anastomosis.
The following surgical data were collected: date of sur-
gery, duration of surgery (skin-to-skin), cross-clamp and
perfusion time, number and types of peripheral anasto-
moses (end-to-end or side-to-side), target vessels, graft ma-
terials and graft compositions used.
Patients receiving a RA graft were treated with a continu-
ous intravenous administration of Nifedipine (Adalat® pro
infusione, Bayer Pharma AG, Germany) on the day of sur-
gery followed by tablets of Nifedipine (Adalat® Oros, Bayer
A/S, Denmark), 30mg, administered once daily for 6
months. All patients received tablets of acetylsalicylic acid
(Takeda Pharma A/S, Denmark), 75mg, once daily starting
on the day of surgery. Patient with a recent preoperative
myocardial infarction or unstable angina and patients who
recently underwent percutaneous coronary intervention
also received tablets of either Ticagrelor (AstraZenica A/S,
Denmark), 90mg b.i.d., or Clopidogrel, 75mg once daily
(Sandoz A/S, Denmark), for 12months, starting when sub-
cutaneous injections of Deltaparin (Pfizer ApS, Denmark)
were discontinued.
High-resolution epicardial ultrasonography using a
stabilizing device
The Medistim VeriQ™ System with a 15-MHz ultrason-
ography probe was used (Medistim A/S, Oslo, Norway).
The ultrasonography probe was connected to a rotatable
plate of a stabilizing device (Echoclip, Aalborg University
Hospital, Denmark) (Fig. 1). The stabilizing device was
designed to receive sterile gel for ultrasonography in the
cavity together with the conduit/anastomosis to be eval-
uated ensuring air-free contact between the transducer
and the anastomosis of interest. Rotation of the plate to
which the probe was attached allowed ultrasonography
of an anastomosis in different planes. The device, which
is not yet commercially available, is a disposable plastic
article tested for biocompatibility according to inter-
national standard ISO 10993-1. The device was pro-
duced with different cavity sizes designed to receive
conduits/anastomoses with different diameters, i.e., from
1mm – 7 mm. This allows anastomoses to be imaged
without applying pressure on the graft when stabilizing
the heart around the anastomosis with the stabilizer.
The device was created with the intention of allowing
ultrasound gel in excess to escape from the cavity during
scanning, reducing the risk of gel being squeezed into
Fig. 1 Schematic drawing of the Echoclip device (Numbers are in millimetres)
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the anastomosis due to an increased pressure around the
anastomosis.
All peripheral anastomoses except in situ internal ar-
tery mammary anastomoses were assessed during aortic
cross-clamp while infusing cold blood cardioplegia dir-
ectly into the free graft just after completion of an anas-
tomosis. ECUS was performed in in situ IMA
anastomoses after the cross-clamp was released while
still on-pump (Fig. 2). We only searched for three spe-
cific anatomical parts of the anastomosis (heel, middle
and toe) and did not aim for a precise evaluation to
identify potential graft failures, as we were not experi-
enced in interpretation of these ultrasonography images
in relation to graft failure.
The surgeon would ensure that the graft was located
in the cavity of the stabilizer in order to avoid obstruc-
tion of the graft flow during the scanning procedure.
Once the stabilizing device with gel was located over the
graft and anastomosis, we tried to identify longitudinal
images of the heel, middle and toe of the anastomosis
using both Doppler colour flow and 2D imaging. After
capturing images in the longitudinal plane, the rotating
disc with the transducer was then turned and aligned
with the coronary artery grafted to obtain transverse im-
ages of the anastomoses. In this transverse plane, we
again tried to identify the heel, middle and toe of the
anastomosis. We considered use of the Echoclip device
to be successful if we were able to obtain images in
which the inner vessel wall of all three parts of an anas-
tomosis (heel, middle and toe) could be identified in at
least 80% of all peripheral anastomoses in both the lon-
gitudinal and transverse planes.
Instillagel®, Farco-Pharma, or the Safergel-sterile ultra-
sonic gel® Safersonic were used as ultrasound gel.
However, after inclusion of the initial four patients we
became aware that no ultrasound gel had been approved
for application in the pericardium during cardiac surgery
even though gel has been used for many years in the
pericardium during both ECUS [7] and TTFM [8]. The
study was therefore put on hold for several months as
we were unable to identify any ultrasound gel approved
for application in the pericardium. Later, we developed a
technique during which we used coagulated blood ob-
tained from the patient before heparinization instead of
gel in order to obtain acoustic contact with the anasto-
moses [6]. In brief, 20–40ml of blood was collected
from the patient through a central venous catheter and
from the surgical field before heparinization. The blood
was left to clot in a sterile plastic cup and later in a
metal cup as the blood did not coagulate sufficiently
when stored in the plastic cup. Coagulated blood was
sucked away from the pericardial space with a wall suc-
tion after the imaging procedure.
Initially, all intraoperative graft assessments using the
Echoclip device were performed by the operating sur-
geon, but after 15 surgeries all intraoperative graft verifi-
cations by ECUS were performed by only one
investigator in order to overcome the learning curve as
fast as possible.
It was registered if the device resulted in or was be
suspected to be involved in an accident or incident re-
gardless of whether the cause was a device malfunction
or misuse.
Transit time flow measurements
TTFM was performed at different time points during
surgery according to the discretion of the surgeon in
addition to ECUS. The first time was after release of the
Fig. 2 Epicardial ultrasonography of the left internal mammary artery anastomosis to the left anterior descending coronary artery in the
longitudinal plane
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cross-clamp when all proximal and distal anastomoses
were performed. The second was after weaning from
ECC before protamine administration, and the third was
after protamine administration. The assessment of graft
failure using TTFM was based on flow curves together
with information regarding diastolic filling percentage
(DF%), pulsatility index (PI), mean flow values and the
blood pressure. No definitive cutoff values defining
graft-failures were used, but in general the surgeons sus-
pected a potential graft failure if the off-pump flow was
< 20ml/min and/or if the PI was > 5. These cut-off
values have previously been suggested in the 2014 ESC/
EACTS Guidelines on myocardial revascularization [9].
Clinical outcome measures
The following in-hospital and 30-day outcomes were reg-
istered: perioperative myocardial infarction defined as an
increase of a biomarker value (Creatinine kinase
isoenzyme-MB) to above five times the 99th percentile of
the normal reference range associated with either the ap-
pearance of a new pathological Q-wave, new left bundle
branch block, angiographic documented graft, native cor-
onary artery occlusion, or imaging evidence of new loss of
viable myocardium [10]; development of acute kidney in-
jury based on the Kidney Disease Improving Global Out-
comes criteria, i.e., an increase in p-creatinine ≥26.5 μmol/
l within 48 h or an increase ≥1.5 times baseline [11]; new
onset atrial fibrillation identified by continuous electrocar-
diographic (ECG) monitoring or a 12-lead ECG; and graft
failure identified by coronary angiography. We also regis-
tered the need for re-intervention due to bleeding or myo-
cardial ischaemia, development of transitory cerebral
ischaemia (TCI) or stroke confirmed by computed tomog-
raphy or magnetic resonance scanning, and deep sternal
wound infection was defined as positive culture results of
the sternal wound or drainage from the mediastinal area.
The in-hospital and 30-day mortality was also registered.
Statistical analyses
A total of 100 patients was planned to be enrolled. The
number of patients to be included was arbitrarily de-
cided. No formal power calculation was performed as
this was a descriptive feasibility study and the Echoclip
device had never been used in patients before. With an
estimated average of 2.5 peripheral anastomoses per pa-
tient and a possible drop-out of 10% of the patients, we
expected to obtain images of approximately 225 periph-
eral anastomoses in 90 patients.
The proportion of successful anastomoses imaged is
given as a percentage of the total number of peripheral
anastomoses performed. Continuous values are expressed
using the median and interquartile range and categorical
variables as percentages. Descriptive statistical data were
retrieved from a REDCap database (Research Electronic
Data Capture; Vanderbilt University, USA).
Results
A total of 56 patients were included in the study be-
tween September 27, 2016 – March 4, 2019. Five pa-
tients were excluded: two patients underwent off-pump
surgery due to the surgeons’ preferences, one patient
underwent percutaneous coronary intervention instead
of CABG due to the patient’s condition on the day of
surgery, one patient needed concomitant aortic valve
surgery, and the log euroSCORE II was > 6 in one pa-
tient. Thus, 51 patients with 155 peripheral coronary
anastomoses were available for analyses. The median age
of the patients was 70 years (interquartile range: 60.5–
73.0 years). We decided to stop recruiting patients after
including 56 non-consecutive patients as we did not ob-
tain any further technical or practical information on
how to use the Echoclip device. A team of six surgeons
performed all operations, but one attending surgeon per-
formed the majority of the ECUS procedures. The 5-mm
Echoclip device was most often used, and the 1-mm
Echoclip device was never used. The learning curve for
obtaining images from anastomoses in different graft
compositions involved approximately 15 patients as im-
aging became easier, faster and more precise after ap-
proximately 15 patients.
Patient characteristics regarding patients in whom
ECUS were performed are shown in Table 1. As ex-
pected, men were more prominent.
Peroperative data are shown in Table 2. All patients re-
ceived a LIMA graft of which most were anastomosed to
the LAD as in situ grafts. Twelve patients underwent total
arterial revascularization with either the LIMA alone (two
patients) or in combination with the RIMA and/or a RA.
ECUS was performed in 153 of the anastomoses. All
ultrasound projections were obtained from 134 of these
anastomoses (87%), and after the initial 15 patients all
six projections were obtained in 100 of 108 scanned
anastomoses (93%). The reasons why all images could
not be obtained from a specific anastomosis were as fol-
lows: a lack of coagulated blood and approved ultra-
sound gel for obtaining optimal acoustic contact
between the ultrasound probe and the anastomosis; a
curved sequential graft with an anastomoses that could
not be contained in the straight cavity of the Echoclip
device; echo artefacts from a Titanium clip located in
the roof of an anastomoses; and challenges in interpret-
ing the images during the learning curve.
Combined use of TTFM and ECUS resulted in imme-
diate revision of a peripheral anastomosis in five differ-
ent patients: TTFM was not acceptable in the LIMA
graft in two patients (Flow < 20ml/min; PI: > 5), and in a
third patient TTFM indicated a problem with a RIMA
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sequential side-to-side anastomosis to an intermediate
coronary artery (Flow < 20 ml/min, PI: > 5). ECUS indi-
cated a graft problem in two of these patients, and ECUS
was not obtained from the side-to-side anastomosis in
the third. During revision of the anastomoses a stenosis
due to a suture was identified in two anastomoses, and
no explanation was found in a LIMA graft. A spasm in
the graft was suspected. Flow was increased in all anas-
tomoses after revision. A fourth patient had an SVG
anastomosed to a marginal coronary artery with no indi-
cation of a flow problem while infusing cardioplegia into
the graft. However, ECUS showed antegrade obstruction
at the toe of the anastomosis (Fig. 3). In a fifth patient,
ECUS indicated an obstruction in a LIMA to the LAD
anastomosis while the TTFM was acceptable (Flow: 26
ml/min; PI: 1.8¸ DF: 69%). Revision of these anastomoses
showed an obstructing intimal flap at the toe in both
anastomoses.
No patients suffered a perioperative myocardial infarc-
tion within 30 days, but one patient experienced recurrent
angina and ventricular fibrillation in the ward on postop-
erative day four. After cardiopulmonary resuscitation, a
coronary re-angiography showed low flow from the LIMA
to the LAD and spasm with thrombus formation in the
sequential RA graft distal to the first and a still-patent
side-to-side anastomosis to a diagonal branch. The
thrombus was causing occlusion of the anastomoses to
the intermediate and the first obtuse marginal artery. The
patient was brought to the operating room, and new anas-
tomoses were constructed. The patient was discharged
after 1 week following the re-operation without any phys-
ical sequelae. ECUS did not indicate any problems during
the primary operation, and TTFM did not indicate any
problems with the sequential graft flow either. However,
TTFM was only performed proximally for the first anasto-
mosis of the sequential graft and distally near the end-to-
side anastomosis. Flow to the intermediate coronary artery
could not be measured due to a titanium clip on the graft.
ECUS was not performed during the re-operation. The
patient had received calcium antagonists according to the
postoperative routine.
A postoperative coronary re-angiography was performed
in three patients in addition to the case mentioned above.
One patient developed ST- elevations in the ECG 16 h
postoperative, and an occlusion of the distal end-to-side
anastomosis of a sequential radial artery to a small obtuse
marginal was diagnosed. A re-angiogram was performed
in another patient with the intention of performing percu-
taneous stenting, as no branches from the circumflex ar-
tery were identified during surgery. All anastomoses were
patent in this patient, and no additional revascularisation
could be performed due to small target vessels. The fourth
Table 1 Preoperative patient characteristics (n = 51)
Female/Male 9 (17.6%) / 42 (82.4%)
Age (years; Median, quartile) 70 (60.5–73.0)
Body mass index (Median, quartile) 27.4 (25.2–30.8)
Hypertension 42 (82.4%)
Diabetes 17 (33.3%)
History of atrial fibrillation (6, 11.8%)
Smoke
Never 11 (21.6%)
Active 11 (21.6%)
Previous 29 (56.8%)
Hypercholesterolemia 44 (86.3%)
Recent myocardial infarction (< 3 months) 8 (15.7%)
Left ventricular ejection fraction (Median,
interquartile range)
60% (50–60%)
p-creatinine (μmol/l)
(Median, interquartile range)
83 (73–94.5)
eGFR (ml/min) 80 (70–90)
Coronary disease (n and %)
1 vessel 2 (3.9%)
2 vessels 13 (25.5%)
3 vessels 36 (70.6%)
Left main stenosis +/− other 16 (31.4%)
Logistic euroSCORE II (Median,
interquartile range)
0.79 (0.72–1.16)
eGFR Estimated glomerular filtration rate
Table 2 Operative details regarding 51 patients undergoing on-
pump coronary artery bypass grafting
Time of surgery skin-to-skin (minutes)
(Median (Interquartile range)
240 (195–275)
Aortic cross clamp (minutes)
(Median (Interquartile range)
65 (48.5–80.0)
Time of cardiopulmonary bypass (minutes)
(Median (Interquartile range)
112 (82.5–128.0)
Number of grafts per patient (Median
(Interquartile range)
3 (2.5–4)
Total number of peripheral anastomoses. 155
End-to-side 124
Side-to-side 31
Number of patients who received
LIMA 51
RIMA 8
SVG 39
Radial artery 15
Anastomoses from which ultrasonography was
obtained in six planes (n; %).
All patients 134/153 (88%)
After the initial 15 patients 100/108 (93%)
LIMA Left internal mammary artery, RIMA Right internal mammary artery, SVG
Saphenous vein graft
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patient was referred for percutaneous revascularisation of
the right coronary artery as this vessel could not be re-
vascularized during surgery. The angiography showed
thrombosis of a vein graft to a small obtuse marginal ar-
tery, and no further attempts to re-vascularize this branch
were pursued. The patient has no signs or symptoms of
myocardial ischaemia.
One patient suffered a stroke. It turned out that this
patient had bilateral stenoses of the internal carotid ar-
teries. No patient experienced symptoms of TCI. New-
onset postoperative atrial fibrillation was diagnosed in
18 patients (36%). Four patients underwent re-
exploration for bleeding. Surgical bleeding was found in
two patients. Five patients developed acute stage 1 kid-
ney injury according to the KDIGO criteria [11], and
none developed deep sternal wound infections. There
was no 30-day or in-hospital mortality.
The blood clots that were used instead of ultrasound gel
produced acoustic signals, and colour Doppler flow was
often needed initially to aid in locating the anastomosis in
the image at the VeriQ system. When this was realized, the
time required for complete ECUS assessment of an anasto-
mosis quickly decreased to 1–1.5min per anastomosis.
More disturbing echo signals on top of the anastomosis
were observed when imaging was performed with the use
of coagulated blood instead of ultrasound gel (Fig. 4).
Discussion
In this prospective clinical feasibility study of 51 on-
pump elective CABG patients with a total of 155 periph-
eral coronary bypass anastomoses, we have shown that
intraoperative use of the Echoclip stabilizing device dur-
ing ECUS successfully facilitates safe imaging in two
planes of anastomoses located in all coronary territories.
As a secondary result, we have shown that ECUS using
the Echoclip device offers the surgeon the possibility of
detecting and revising a graft failure that would other-
wise not have been identified by the use of TTFM alone.
Early graft occlusions have been described to occur in
5–10% of the grafts in patients undergoing CABG [12].
Failures that may be detected during intraoperative graft
assessment include twisting of the graft, anastomosis
stenosis, a narrow toe of the anastomosis, kinked graft,
etc. Ultimately, intraoperative ECUS with the use of a
stabilizing device may limit the need for repeat revascu-
larization and help reduce adverse events resulting from
technical graft failures early after CABG. In the present
study, the surgeons revised five (3.2%) peripheral anasto-
moses based on combined TTEM and ECUS due to
technical failures. In two of these cases, TTFM did not
indicate any graft problems. These graft failures may
have resulted in signs and symptoms of graft failure by
the end of surgery, but early graft occlusion may be si-
lent [13]. Technical failures that are not detected during
the operation may increase the risk of postoperative is-
chaemia, myocardial infarction or sudden death in the
postoperative period.
In the present study, we arbitrarily decided to include
100 patients. However, after having included more than
half of the intended number of patients, we realized that
we did not obtain any further technical knowledge on
how to use the Echoclip device in different coronary ter-
ritories. Therefore, we decided to end the study. Further-
more, as we did not aim to predict early graft failure and
clinical outcomes based on the results from this study,
we found the number of included patients to be suffi-
cient for a feasibility study.
There were no adverse events suspected to be associ-
ated with the use of the Echoclip device. One patient ex-
perienced a major cardiac event on postoperative day
four. Manipulation of arterial grafts, which may happen
during ECUS, may potentially have cause spasm in the
grafts and caused occlusion. However, due to the time
from ECUS to the major cardiac event, we find it rea-
sonable to conclude that this was unrelated to the intra-
operative ECUS procedure. The number of patients
experiencing mild, acute kidney injury is in accordance
with the incidence described in the literature following
cardiac surgery. Early postoperative kidney injury may
be diagnosed with an incidence between 8.9–39% follow-
ing cardiac surgery depending on the type of surgery
and diagnostic criteria [14, 15]; although there was a
relatively high number of reoperations due to bleeding
(8%), we have no reason to believe that this was related
to the ECUS procedure.
Thus, clinical evidence from the present study supports
the safety of the stabilizing device. To our knowledge,
there is no published evidence in the English literature of
adverse events in relation to ECUS in general.
We did not compare the effectiveness of performing
ECUS with and without the Echoclip device. However,
the use of a stabilizing device may be a more effective al-
ternative compared with ECUS without the device be-
cause use of the device offers the surgeon the
opportunity to keep the ultrasound transducer in air-
free contact with the anastomosis without the risk of
deforming the anastomosis while looking at the ultra-
sound images at the screen.
Sterile water-soluble ultrasound gel was used as the
acoustic coupling fluid in the initial four patients. During
surgery, the gel may be sucked from the pericardium into
the heart-lung machine, and the gel may eventually end
up in the patient’s circulation. However, there is no infor-
mation in the literature on whether this may cause any
harmful effects. Use of coagulated blood instead of gel has
several limitations in addition to producing more noisy
echo signals. First, blood clots are problematic to use, as
the surgeon must remember to collect blood from the
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patient before heparinization. Second, clotted blood is a
limited resource after heparinization, and third, blood
clots are more slippery than gel. This makes it more diffi-
cult to keep the blood clot in place inside the Echoclip de-
vice compared with gel. In contrast with the blood clot,
gel can be applied after the stabilizing device with the echo
probe is positioned on top of an anastomosis. An ultra-
sound gel should be developed and approved for applica-
tion in the pericardial space during cardiac surgery.
Surgeons must overcome a learning curve in relation to
the use of ECUS of peripheral coronary anastomoses. Expe-
rienced surgeons have indicated that the basics can be
learned in approximately 10–20 grafts [16, 17]. This is con-
sistent with the learning curve experienced in the present
study.
Interpreting ECUS images may be difficult. However,
recent studies have proposed methods for automatic
anastomosis segmentation, which may provide quantita-
tive analysis of ECUS images to aid the interpretation in
clinical practice in the future [18].
In addition to peroperative graft assessment, ECUS
can also be used for surgical guidance, e.g., epi-aortic
scanning in order to identify non-palpable soft arterio-
sclerotic plaques, detect coronary vessels embedded in
Fig. 3 Doppler colour flow images showing a vein graft anastomosis with stenosis at the toe (a) and after revision of the anastomoses (b)
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the myocardium, and assess native coronary arteries for
the optimal site for anastomoses [17]. This can be done
without a stabilizing device.
In addition to a potential patient impact of ECUS with
the stabilizing device, there may also be a potential sys-
tem impact. The possibility of revising a graft failure be-
fore the patient leaves the operation room was observed,
and this may be a key benefit to the healthcare system;
however, we did not perform a health economic analysis.
The Echoclip device is still not commercially available,
but additional costs of the Echoclip technology will
probably only have a minor impact on resources, espe-
cially if a MiraQ system is already available. Use of
ECUS and the stabilizing device requires minimal train-
ing and has a short learning curve.
Some limitations of this study must be mentioned.
First, although several surgeons participated in interpret-
ing the images during surgery in order to identify the
heel, middle and toe of the anastomoses in two planes, a
majority of the ECUS procedures were performed by a
single surgeon. Therefore, the results regarding the
learning curve may not be generalizable. Second, pa-
tients were not included consecutively for practical rea-
sons. Thus, there is risk of bias with regard to the
inclusion of patients. After having included the initial 15
patients, we included patients based on availability of the
surgeon who was most experienced with the use of the
Echoclip device, but we have no reason to believe that
patients were systematically included based on specific
clinical and para-clinical data. Third, a coronary angio-
gram, which is considered to be the most accurate tech-
nique for graft assessment, was not performed per- or
postoperative as a routine, and therefore we cannot
evaluate the diagnostic accuracy of the ECUS procedures
performed in this feasibility study. Fourth, we did not
compare TTFM to the ECUS findings; however, as we
did not aim to evaluate the combined use of TTFM and
ECUS, we consider this a minor limitation. Fifth, the
study was performed in a small centre with a relatively
small number of patients. Furthermore, the study was
limited to on-pump surgery.
Future studies on the Echoclip device will be conduct
to perform blinded comparisons of UL images obtained
from the same anastomosis with and without use of the
device using algorithms for automatic estimation [18] of
the anastomotic quality. Furthermore, the Echoclip de-
vice will be tested during off-pump surgery. An ultra-
sound gel to be approved for application in the
pericardial space should be developed, and we also in-
tend to obtain a CE marking (Conformité Européenne)
for the Echoclip device as a symbol of free marketability
in the European Economic Area.
Fig. 4 Epicardial ultrasonography of coronary anastomoses with either gel (A + B) or coagulated blood (C + D) as the acoustic coupling fluid
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Conclusions
Peroperative use of a stabilizing device during ultrason-
ography of coronary artery bypass anastomoses during
on-pump surgery facilitates imaging and provides sur-
geons with non-deformed longitudinal and transverse
images of all parts of the anastomoses in all coronary
territories. Peroperative ECUS in addition to flow mea-
surements has the potential to increase the likelihood of
detecting technical errors in constructed anastomoses.
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